TR201722323A2 - Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari - Google Patents

Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari

Info

Publication number
TR201722323A2
TR201722323A2 TR2017/22323A TR201722323A TR201722323A2 TR 201722323 A2 TR201722323 A2 TR 201722323A2 TR 2017/22323 A TR2017/22323 A TR 2017/22323A TR 201722323 A TR201722323 A TR 201722323A TR 201722323 A2 TR201722323 A2 TR 201722323A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
dabigatran
oral pharmaceutical
dabigatran etexilate
componenet
Prior art date
Application number
TR2017/22323A
Other languages
English (en)
Inventor
Palantöken Arzu
Türkyilmaz Ali̇
Gülkok Yildiz
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22323A priority Critical patent/TR201722323A2/tr
Priority to PCT/TR2018/050901 priority patent/WO2019132839A1/en
Priority to EP18877293.3A priority patent/EP3731822A1/en
Publication of TR201722323A2 publication Critical patent/TR201722323A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, dabigatran eteksilat serbest bazını veya dabigatran eteksilatın farmasötik olarak kabul edilebilir tuzlarını içeren bir birinci bileşen ve bir organik asit içeren bir ikinci bileşen içeren oral uygulama için farmasötik kompozisyonlarla ilgilidir.
TR2017/22323A 2017-12-27 2017-12-27 Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari TR201722323A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/22323A TR201722323A2 (tr) 2017-12-27 2017-12-27 Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari
PCT/TR2018/050901 WO2019132839A1 (en) 2017-12-27 2018-12-26 Oral pharmaceutical compositions of dabigatran
EP18877293.3A EP3731822A1 (en) 2017-12-27 2018-12-26 Oral pharmaceutical compositions of dabigatran

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22323A TR201722323A2 (tr) 2017-12-27 2017-12-27 Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari

Publications (1)

Publication Number Publication Date
TR201722323A2 true TR201722323A2 (tr) 2019-07-22

Family

ID=66476807

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22323A TR201722323A2 (tr) 2017-12-27 2017-12-27 Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari

Country Status (3)

Country Link
EP (1) EP3731822A1 (tr)
TR (1) TR201722323A2 (tr)
WO (1) WO2019132839A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112266475B (zh) * 2020-11-05 2022-02-22 中国科学院长春应用化学研究所 一种二氧化碳聚酯多元醇、全生物降解二氧化碳基聚氨酯及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
CA2476054C (en) 2002-03-07 2011-11-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
DE10337697A1 (de) 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
DE102005020002A1 (de) 2005-04-27 2006-11-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
PL2588090T3 (pl) 2010-07-01 2017-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Doustne farmaceutyczne postacie dawkowania zawierające eteksylan dabigatranu i jego farmaceutycznie dopuszczalne sole
US9006448B2 (en) 2010-12-06 2015-04-14 Msn Laboratories Private Limited Process for the preparation of benzimidazole derivatives and its salts
HUE056194T2 (hu) 2012-02-21 2022-01-28 Towa Pharmaceutical Europe S L Dabigatrán-etexilát orális gyógyszerészeti készítményei
IN2013CH05441A (tr) * 2013-11-26 2015-05-29 Aurobindo Pharma Ltd
IN2014MU01042A (tr) * 2014-03-26 2015-10-02 Cadila Healthcare Ltd
KR20170070635A (ko) * 2015-12-14 2017-06-22 한미약품 주식회사 다비가트란 이텍실레이트를 함유하는 복합 캡슐제

Also Published As

Publication number Publication date
WO2019132839A1 (en) 2019-07-04
EP3731822A1 (en) 2020-11-04

Similar Documents

Publication Publication Date Title
JOP20200122A1 (ar) مركبات مفيدة لتثبيط cdk7
SA519410865B1 (ar) مركب حلقي شبيه بكُومارين بوصفه مثبط mek واستخدامه
NZ780890A (en) Pharmaceutical compositions comprising meloxicam
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
IN2013CH05441A (tr)
PH12017500029A1 (en) 4,5-dihydroisoxazole derivatives as nampt inhibitors
IN2014MN02245A (tr)
IL264880A (en) Preparations for oral administration of active substances
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2014MU01042A (tr)
MX2023012198A (es) Composiciones de amantadina, preparaciones de estas y metodos de uso.
WO2016142821A3 (en) Compositions containing a thrombin inhibitor
NZ740587A (en) Fluoroindole derivatives as muscarinic m1 receptor positive allosteric modulators
MX385513B (es) Composiciones farmaceuticas que comprenden safinamida.
TR201722323A2 (tr) Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari
WO2020032885A3 (en) Capsule-in-capsule compositions of dabigatran etexilate
WO2019004980A3 (en) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE
IN2014MU00859A (tr)
TR201722186A2 (tr) Dabi̇gatranin farmasöti̇k kompozi̇syonlari
WO2019151966A3 (en) Pharmaceutical tablet compositions of dabigatran
IN2013MU03421A (tr)